Clinical Trial Update: Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)

View source ↗

Summary

A terminated clinical trial update reports adherence data for patients with chronic hepatitis C treated with PegIntron and Rebetol under a patient assistance pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepacivirus | Status: TERMINATED